Answer
Breastfeeding is contraindicated during azacitidine (Vidaza) treatment because of potential serious adverse reactions in the nursing child, although whether azacitidine or its metabolites enter human milk is unknown.
Sources for this answer
- Vidaza 25 mg/ml powder for suspension for injectionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 25Document updated
Sources checked